Cross-market pharmaceutical NET price and discount benchmark panel

Name: Cross-market pharmaceutical NET price and discount benchmark panel: estimated net (post-discount) drug prices and gross-to-net spreads at therapy level across 40+ developed and emerging markets, on a uniform cross-market methodology, with event annotations for new launches, significant price adjustments, volume shifts and patient-support programme changes, plus a monthly analyst narrative layer explaining the drivers behind net price movements.
Creator: Vamstar

VAMSTARManage supplier listing

Cross-market pharmaceutical NET price and discount benchmark panel: estimated net (post-discount) drug prices and gross-to-net spreads at therapy level across 40+ developed and emerging markets, on a uniform cross-market methodology, with event annotations for new launches, significant price adjustments, volume shifts and patient-support programme changes, plus a monthly analyst narrative layer explaining the drivers behind net price movements.

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Vamstar and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: Pharmaceuticals
Instruments: equities
Categories: AlternativeFundamentalReference

Dataset card

Type: not stated
Format: Tabular (therapy x market x period net price / discount panel) delivered via platform, with a monthly analytical bulletin layer (text) and AI-assisted analytics on top
Volume: Order of 10^5-10^6 therapy-market-period net price observations (40+ markets x several hundred therapy areas x monthly/quarterly periods since launch), plus a comparable count of annotated change events and driver attributions
Users: ~50-200 subscription seats (inferred: 82-employee London analytics firm at ~EUR 4.9M revenue, enterprise subscription product with analyst support rather than self-serve signup)
History: 6 years
Update frequency: not stated
Growth: Active — product page is current-generation (assets uploaded 2024/08) and explicitly advertises 'upcoming enhancements to pricing capabilities and market intelligence' alongside AI-assisted analytics build-out
Launched: ~2024 for this product (page assets dated 2024/08); Vamstar as a company is older, having raised funding earlier, so the Net Price Tracker is a later productisation of an existing analytics practice
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site